Alto Neuroscience, Inc. (ANRO) KPIs and segments

ANRONYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30

$29.54−1.08 (-3.53%)

Close on Nov 13, 2026Market cap $1.16BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Alto Neuroscience's business

Coming soon

This tab will track the numbers specific to Alto Neuroscience's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?